# OnCo record paper-lyma-rituximab-maintenance-after-transplant-mantle-cell-nejm-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-lyma-rituximab-maintenance-after-transplant-mantle-cell-nejm-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-lyma-rituximab-maintenance-after-transplant-mantle-cell-nejm-2017" ;
  schema:name "Rituximab after autologous stem-cell transplantation in mantle-cell lymphoma"@en ;
  schema:alternateName "LyMa"@en, "Le Gouill 2017"@en ;
  schema:description "Three years of an antibody every two months after a stem cell transplant kept younger people with mantle cell lymphoma in remission longer and helped them live longer."@en ;
  schema:url <https://onco.cc/key-papers/paper-lyma-rituximab-maintenance-after-transplant-mantle-cell-nejm-2017/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1701769>, <https://pubmed.ncbi.nlm.nih.gov/28953447/>, <https://europepmc.org/article/MED/28953447> ;
  onco:tag "lymphoma-evidence" ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1701769> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Le Gouill S, Thieblemont C, Oberic L, et al." ;
  onco:related <https://onco.cc/roadmaps/lymphoma-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/mantle-cell-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/cell-therapy/> ;
  onco:targets <https://onco.cc/targets/cd20/>, <https://onco.cc/targets/ccnd1/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/dexamethasone/>, <https://onco.cc/drugs/cytarabine/>, <https://onco.cc/drugs/cisplatin/> ;
  onco:companies <https://onco.cc/companies/lysa/> ;
  onco:terms <https://onco.cc/terms/maintenance-therapy/>, <https://onco.cc/terms/autologous-transplant/>, <https://onco.cc/terms/lymphoma-tx-transplant-role/> ;
  onco:trials <https://onco.cc/trials/lyma/>, <https://onco.cc/trials/triangle/> ;
  onco:people <https://onco.cc/people/catherine-thieblemont/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-toxicity-qol/> ;
  onco:journals <https://onco.cc/journals/nejm/> .